EPOK Therapeutics

Operator of a clinical-stage biopharmaceutical company intended to develop novel antibody-based therapeutics for the treatment of metabolic diseases. The company's lead product candidate is an antibod...

Healthcare
Toronto, Canada
Founded 2023
5 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$6.7M
Last Round
N/A

Get the full picture

Create a free account to unlock EPOK Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required